Kristin Wipfler, PhD

FORWARD, The National Databank for Rheumatic Diseases
Omaha, NE, United States

Dr. Wipfler is the Biobank Director at FORWARD, The National Databank for Rheumatic Diseases. She leads FORWARD's biobank studies and is an analyst for epidemiological studies. Her primary research interests include genetic biomarkers related to development, progression, and drug response in RMDs, as well as patient-reported outcomes with respect to health disparities, use of complementary medicine, and patient experiences during the COVID-19 pandemic.

Disclosure information not submitted.

Presentation(s):

• 0912: Associations Between Fatty Acid Amide Hydrolase Variants and Response to Cannabis Use for Pain Management in Rheumatoid Arthritis

  Saturday, November 12, 2022
  1:00 PM – 1:05 PM Eastern Time

• 0912: Associations Between Fatty Acid Amide Hydrolase Variants and Response to Cannabis Use for Pain Management in Rheumatoid Arthritis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1137: MHC Class I Polypeptide-Related Sequence a Variant Predicts Real-World Response to Anti-TNF Therapy

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1952: Burden of Disease in Refractory Rheumatoid Arthritis

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• L09: Impact on Access to Methotrexate in the Post-Roe Era

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• L09: Impact on Access to Methotrexate in the Post-Roe Era

  Monday, November 14, 2022
  2:10 PM – 2:15 PM Eastern Time